Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in HUMA — Humacyte, Inc.

CIK 1115418 BOSTON, MA
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$55,723
-$50,228 QoQ
Shares Held
71,441
-59.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 163 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. HUMA ranks #291 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in HUMA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,723 71,441
2026-03-31 $105,951 174,549
2025-12-31 $171,216 178,165
2025-09-30 $305,333 175,479
2025-06-30 $371,232 177,623
2025-03-31 $200,446 117,564
2024-12-31 $577,997 114,455
2024-09-30 $595,408 109,450
2024-06-30 $532,411 110,919
2024-03-31 $183,679 59,061
2023-12-31 $161,525 56,875
2023-09-30 $160,988 54,945
2023-06-30 $153,044 53,512
2023-03-31 $151,756 49,112
2022-12-31 $108,255 51,306
2022-09-30 $74,275 22,784
2022-06-30 $68,790 21,430